Cell C listing triggers R5.2bn hit on Blu Label By Nicola Mawson, Contributing journalistJohannesburg, 19 Feb 2026BLU’s carrying value of Cell C has dropped. (Photograph by Nicola Mawson) JSE-listed ...

In a 2023 paper on hypoxia and glucose metabolism, our lab showed how organisms rewire their metabolism to adapt to low oxygen levels—such as those found at high altitudes. One of the most striking ...

Protein-Protein Interactions (PPIs) are critical for biological systems to function properly. Strong interactions maintain structural integrity and function, whereas weaker interactions enable ...

Blue Label’s long-awaited reset is underway. In this Director’s Cut, Sharenet Wealth portfolio manager Dylan Bradfield unpacks Cell C’s first post-listing resul ...

Cell C is no longer technically insolvent according to its first set of financial results since listing on the JSE.

Cordex plans to work with German transplant centres on individual NUB applications and expand clinical adoption.

In accordance with paragraph 6.26 (a) and 6.30 of the Listings Requirements of the JSE Limited, shareholders are advised that the Company expects basic earnings per share for the six-month period ...

Cell C pleases market with maiden numbers By Nicola Mawson, Contributing journalistJohannesburg, 13 Feb 2026Cell C CEO Jorge Mendes. (Photograph by Nicola Mawson) Cell C’s maiden interim results for ...

Mobile telecommunications operator Cell C has reported a modest 1.65% year-on-year increase in revenue for the six months ended November.

Nine defendants are going on trial in Fort Worth for an alleged "Antifa" ambush on an Alvarado ICE detention center that resulted in the shooting of a police officer and the first-of-its-kind federal ...

If the Excel chart labels disappeared, you need to make some changes to your chart. In this post, we will look at those changes.

Following over a year of slow uptake, Vertex Pharmaceuticals and CRISPR Therapeutics expect Casgevy revenues to nearly triple ...